Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel

NCT02140801 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

352

Enrollment

OTHER

Sponsor class

Conditions

Thrombosis

Interventions

DRUG: Ticagrelor
DRUG: Clopidogrel

Sponsor

Nanjing First Hospital, Nanjing Medical University